HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph Negri Selected Research

AAL 881

3/2007Targeting BRAFV600E in thyroid carcinoma: therapeutic implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph Negri Research Topics

Disease

8Neoplasms (Cancer)
08/2011 - 05/2005
6Multiple Myeloma
08/2011 - 10/2006
5Thyroid Neoplasms (Thyroid Cancer)
12/2007 - 05/2005
4Retinoblastoma (Glioblastoma, Retinal)
09/2009 - 01/2005
2Myocardial Infarction
11/2018 - 01/2015
2Medullary Carcinoma
10/2006 - 05/2005
1Schizophrenia (Dementia Praecox)
01/2020
1Synucleinopathies
10/2019
1Parkinson Disease (Parkinson's Disease)
10/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2015
1Carcinogenesis
02/2011
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
09/2009
1Oncogene Addiction
12/2007
1Hematologic Neoplasms (Hematological Malignancy)
10/2006
1Anaplastic Thyroid Carcinoma
10/2006
1Carcinoma (Carcinomatosis)
09/2006

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
12/2007 - 05/2005
3Pharmaceutical PreparationsIBA
10/2019 - 10/2007
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2007 - 10/2006
3Bortezomib (Velcade)FDA Link
12/2007 - 10/2006
3Proteasome InhibitorsIBA
12/2007 - 10/2006
2Triglycerides (Triacylglycerol)IBA
11/2018 - 01/2015
2LDL CholesterolIBA
11/2018 - 01/2015
2HDL CholesterolIBA
11/2018 - 01/2015
2VorinostatFDA Link
09/2009 - 05/2005
2Histone Deacetylase InhibitorsIBA
09/2009 - 05/2005
2Complementary DNA (cDNA)IBA
12/2007 - 05/2005
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
10/2007 - 05/2005
2CaspasesIBA
10/2007 - 05/2005
2Antineoplastic Agents (Antineoplastics)IBA
10/2007 - 10/2006
2NF-kappa B (NF-kB)IBA
10/2007 - 10/2006
2Death Domain ReceptorsIBA
05/2005 - 01/2005
2Caspase 8 (Caspase-8)IBA
05/2005 - 01/2005
1LipidsIBA
10/2019
1SynucleinsIBA
10/2019
1sulforaphaneIBA
08/2011
1isothiocyanic acidIBA
08/2011
1phenethyl isothiocyanate (PEITC)IBA
08/2011
1IsothiocyanatesIBA
08/2011
1PhytochemicalsIBA
08/2011
1Transcription Factors (Transcription Factor)IBA
02/2011
1Heterocyclic Compounds (Compounds, Heterocyclic)IBA
02/2011
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2011
1BI 2536IBA
01/2011
1Phosphotransferases (Kinase)IBA
01/2011
1Histone Deacetylases (Histone Deacetylase)IBA
09/2009
1Sirolimus (Rapamycin)FDA Link
07/2009
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2009
1Propidium (Propidium Iodide)IBA
10/2007
1thiazolyl blueIBA
10/2007
1AAL 881IBA
03/2007
1RNA (Ribonucleic Acid)IBA
03/2007
1MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA
03/2007
1MitogensIBA
03/2007
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2007
1Proto-Oncogene Proteins B-rafIBA
03/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2006
1Messenger RNA (mRNA)IBA
09/2006
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
09/2006
1AEE 788 (AEE788)IBA
09/2006
1ErbB Receptors (EGF Receptor)IBA
09/2006
1AcidsIBA
05/2005
1Monoclonal AntibodiesIBA
01/2005

Therapy/Procedure

4Drug Therapy (Chemotherapy)
12/2007 - 05/2005
3Therapeutics
08/2011 - 12/2007
1Electrodes (Electrode)
01/2020